home / stock / glyc / glyc quote
Last: | $1.71 |
---|---|
Change Percent: | 2.96% |
Open: | $1.8 |
Close: | $1.71 |
High: | $1.8105 |
Low: | $1.695 |
Volume: | 546,135 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.71 | $1.8 | $1.71 | $1.8105 | $1.695 | 546,135 | 04-25-2024 |
$1.855 | $1.99 | $1.855 | $1.99 | $1.79 | 656,793 | 04-24-2024 |
$1.835 | $1.8 | $1.835 | $1.86 | $1.74 | 1,229,295 | 04-23-2024 |
$1.8 | $1.94 | $1.8 | $2.05 | $1.8 | 1,477,807 | 04-22-2024 |
$1.925 | $2.17 | $1.925 | $2.17 | $1.88 | 1,169,156 | 04-19-2024 |
$2.16 | $2.29 | $2.16 | $2.3577 | $2.15 | 876,083 | 04-18-2024 |
$2.28 | $2.16 | $2.28 | $2.39 | $2.16 | 845,958 | 04-17-2024 |
$2.15 | $2.24 | $2.15 | $2.33 | $2.14 | 599,070 | 04-16-2024 |
$2.255 | $2.4 | $2.255 | $2.465 | $2.22 | 763,637 | 04-15-2024 |
$2.4 | $2.5 | $2.4 | $2.53 | $2.32 | 520,258 | 04-12-2024 |
$2.505 | $2.57 | $2.505 | $2.57 | $2.48 | 485,402 | 04-11-2024 |
$2.45 | $2.68 | $2.45 | $2.73 | $2.42 | 959,276 | 04-10-2024 |
$2.68 | $2.62 | $2.68 | $2.71 | $2.59 | 763,775 | 04-09-2024 |
$2.59 | $2.81 | $2.59 | $2.81 | $2.56 | 698,765 | 04-08-2024 |
$2.75 | $2.81 | $2.75 | $2.83 | $2.66 | 394,668 | 04-05-2024 |
$2.71 | $2.79 | $2.71 | $2.86 | $2.68 | 404,681 | 04-04-2024 |
$2.765 | $3 | $2.765 | $3.02 | $2.72 | 586,213 | 04-03-2024 |
$2.96 | $3.01 | $2.96 | $3.16 | $2.91 | 391,837 | 04-02-2024 |
$3.04 | $3.06 | $3.04 | $3.14 | $3 | 719,907 | 04-01-2024 |
$3 | $3.07 | $3 | $3.11 | $2.9 | 652,824 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you will be provided with dial ...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...